-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Promoting Minorities in Hematology (PMH) Oral Presentations: Room II (for in-person participants)

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Diversity, Equity, and Inclusion (DEI)
Saturday, December 9, 2023: 6:30 PM-8:00 PM
Marina Ballroom E (Marriott Marquis San Diego Marina)
ASH invites all interested meeting attendees to this event, which will showcase training and research opportunities geared toward increasing the diversity scholars in the field of hematology. The highlight of the session will be scientific presentations from the ASH Minority Medical Student Award, the ASH Minority Resident Hematology Award, the ASH Minority Hematology Graduate Award, and the ASH Minority Hematology Fellowship Award program participants.

A special reception celebrating the 20th anniversary of the Minority Recruitment Initiative (MRI) will follow presentations.

Validation of a Natural Language Processing Tool for Identification of Acute Deep Venous Thrombosis

Abdi Abud

University of Missouri-Columbia School of Medicine, Saint Louis, MO
Intellectual Disability, Cancer, and Delayed Diagnosis: A Scoping Review

Andres Felipe Fajardo, MD

McMaster University, Hamilton, ON, CAN
Investigating the Impact of Neighborhood Deprivation Level on Late-Term Outcomes in Adolescent and Young Adult Hodgkin Lymphoma Survivors

Elizabeth Rodriguez

The University of Texas Health Science Center at Houston, Houston, TX
Health Disparities in Acute Lymphoblastic Leukemia (ALL): A Focus on Adolescent and Young (AYA) Adult Patients and Temporal Trends over Ten Years

Elyse Lopez, MD

Department of Internal Medicine, Baylor College of Medicine, Houston, TX
Delineating How Obesity-Associated Chronic Inflammation Impacts B-Cell Acute Lymphoblastic Leukemia (B-ALL) Progression

Jamie A.G. Hamilton, PhD

Emory University, Atlanta, GA
Marital Status, Frailty, and Survival in Older Adults with Blood Cancer

Jorge David Avila, MD

St. Elizabeth's Medical Center, Boston, MA
Assessing the Risk of Venous Thromboembolism and Bleeding Among Patients with Myeloproliferative Neoplasms Undergoing Total Knee and Hip Arthroplasty

Josue Marquez-Garcia

The Warren Alpert Medical School of Brown University, Arlington, MA
Association of Latino Ethnicity with Cytogenetic Subtype in Pediatric Acute Lymphoblastic Leukemia: A Report from the Reducing Ethnic Disparities in Acute

Maria D. Leon-Camarena, MD

Internal Medicine, Dell Medical School at University of Texas, Austin, TX
Biomarker, Cytokine and Gene Expression Signatures of Alloimmunization in Children with Sickle Cell Disease

Oluwalonimi Adebowale, MD

Howard University College of Medicine, Washington, DC
Defining the Clinical Outcomes and Molecular Landscape of Acute Myeloid Leukemia (AML) in Nigeria

Omolegho Momoh, MD

Montefiore New Rochelle Hospital, New Rochelle, NY
Approaches to Evaluate HbF Determinants in Genome Editing for Sickle Cell Disease

Tolulope Rosanwo, MD

Boston Children's Hospital, Boston, MA
See more of: Special-Interest Sessions
<< Previous Session | Next Session >>